According to Civeo's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -30.6098. At the end of 2022 the company had a P/E ratio of -81.8.
Year | P/E ratio | Change |
---|---|---|
2022 | -81.8 | -42.08% |
2021 | -141 | 9893.52% |
2020 | -1.41 | -59.44% |
2019 | -3.49 | 114.55% |
2018 | -1.62 | -51.79% |
2017 | -3.37 | 37.88% |
2016 | -2.44 | 113.48% |
2015 | -1.15 | -50.64% |
2014 | -2.32 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Sapiens SPNS | 33.8 | -210.54% | ๐ฎ๐ฑ Israel |
Shift4 Payments
FOUR | 34.0 | -211.01% | ๐บ๐ธ USA |
Castlight Health
CSLT | N/A | N/A | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.